Bacteriocins from Lactic Acid Bacteria: Production, Purification, and Food ApplicationsDe Vuyst L. · Leroy F.
Department of Applied Biological Sciences and Engineering, Research Group of Industrial Microbiology and Food Biotechnology, Vrije Universiteit Brussel, Brussels, Belgium
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
In fermented foods, lactic acid bacteria (LAB) display numerous antimicrobial activities. This is mainly due to the production of organic acids, but also of other compounds, such as bacteriocins and antifungal peptides. Several bacteriocins with industrial potential have been purified and characterized. The kinetics of bacteriocin production by LAB in relation to process factors have been studied in detail through mathematical modeling and positive predictive microbiology. Application of bacteriocin-producing starter cultures in sourdough (to increase competitiveness), in fermented sausage (anti-listerial effect), and in cheese (anti-listerial and anti-clostridial effects), have been studied during in vitro laboratory fermentations as well as on pilot-scale level. The highly promising results of these studies underline the important role that functional, bacteriocinogenic LAB strains may play in the food industry as starter cultures, co-cultures, or bioprotective cultures, to improve food quality and safety. In addition, antimicrobial production by probiotic LAB might play a role during in vivo interactions occurring in the human gastrointestinal tract, hence contributing to gut health.
© 2007 S. Karger AG, Basel
Wood BJB, Holzapfel WH: The Genera of Lactic Acid Bacteria. London, Blackie Academic & Professional, 1995.
- Leroy F, De Vuyst L: Lactic acid bacteria as functional starter cultures for the food fermentation industry. Trends Food Sci Technol 2004;15:67–78.
- Leroy F, Verluyten J, De Vuyst L: Functional meat starter cultures for improved sausage fermentation. Int J Food Microbiol 2006;106:270–285.
De Vuyst L, Avonts L, Makras L: Probiotics, prebiotics and gut health; in Remacle C, Reusens B (eds): Functional Foods, Ageing and Degenerative Disease. Cambridge, Woodhead Publishing, 2004, pp 416–482.
De Vuyst L, Vandamme EJ: Bacteriocins of Lactic Acid Bacteria: Microbiology, Genetics and Applications. London, Blackie Academic & Professional, 1994.
- Lavermicocca P, Valerio F, Evidente A, Lazzaroni S, Corsetti A, Gobbetti M: Purification and characterization of novel antifungal compounds from the sourdough Lactobacillus plantarum strain 21B. Appl Environ Microbiol 2000;66:4084–4090.
- Strøm K, Sjøgren J, Broberg A, Schnürer J: Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid. Appl Environ Microbiol 2002;68:4322–4327.
- Schnürer J, Magnusson J: Antifungal lactic acid bacteria as biopreservatives. Trends Food Sci Technol 2005;16:70–78.
- Makras L, Triantafyllou V, Fayol-Messaoudi D, Adriany T, Zoumpopoulou G, Tsakalidou E, Servin A, De Vuyst L: Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds. Res Microbiol 2006;157:241–247.
- Nes IF, Johnsborg O: Exploration of antimicrobial potential in LAB by genomics. Curr Opin Biotechnol 2004;15:100–104.
- Cotter PD, Hill C, Ross RP: Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005;3:777–788.
- Riley MA, Wertz JE: Bacteriocins: evolution, ecology, and application. Annu Rev Microbiol 2002;56:117–137.
- Ennahar S, Sonomoto K, Ishizaki A: Class IIa bacteriocins from lactic acid bacteria: antibacterial activity and food preservation. J Biosci Bioeng 1999;87:705–716.
- Klaenhammer TR: Bacteriocins of lactic acid bacteria. Biochimie 1988;70:337–349.
- Vogel RF, Pohle BS, Tichaczek PS, Hammes WP: The competitive advantage of Lactobacillus curvatus LTH1174 in sausage fermentations is caused by formation of curvacin A. Syst Appl Microbiol 1993;16:457–462.
- Stevens KA, Sheldon BW, Klapes NA, Klaenhammer TR: Nisin treatment for inactivation of Salmonella species and other Gram-negative bacteria. Appl Environ Microbiol 1991;57:3613–3615.
- Ennahar S, Sashihara T, Sonomoto K, Ishizaki A: Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev 2000;24:85–106.
Twomey D, Ross RP, Ryan M, Meaney B, Hill C: Lantibiotics produced by lactic acid bacteria: structure, function and applications. Antonie van Leeuwenhoek 2002;82:165–185.
- Leroy F, De Vuyst L: Simulation of the effect of sausage ingredients and technology on the functionality of the bacteriocin-producing Lactobacillus sakei CTC 494 strain. Int J Food Microbiol 2005;100:141–152.
Leroy F, De Vuyst L: Sakacins; in Naidu AS (ed.): Natural Food Antimicrobial Systems. Boca Raton, CRC Press LLC, 2000, pp 589–610.
- Yang R, Johnson MC, Ray B: Novel method to extract large amounts of bacteriocins from lactic acid bacteria. Appl Environ Microbiol 1992;58:3355–3359.
De Vuyst L, Callewaert R, Crabbé K: Primary metabolite kinetics of bacteriocin biosynthesis by Lactobacillus amylovorus and evidence for stimulation of bacteriocin production under unfavourable growth conditions. Microbiology 1996;142:817–827.
- Lejeune R, Callewaert R, Crabbé K, De Vuyst L: Modelling the growth and bacteriocin production by Lactobacillus amylovorus DCE 471 in batch cultivation. J Appl Microbiol 1998;84:159–168.
- Leroy F, De Vuyst L: Temperature and pH conditions that prevail during the fermentation of sausages are optimal for the production of the antilisterial bacteriocin sakacin K. Appl Environ Microbiol 1999;65:974–981.
- Van den Berghe E, Skourtas G, Tsakalidou E, De Vuyst L: Streptococcus macedonicus ACA-DC 198 produces the lantibiotic, macedocin, at temperature and pH conditions that prevail during cheese manufacture. Int J Food Microbiol 2006;107:138–147.
- Callewaert R, De Vuyst L: Bacteriocin production with Lactobacillus amylovorus DCE 471 is improved and stabilized by fed-batch fermentation. Appl Environ Microbiol 2000;66:606–613.
- Leroy F, De Vuyst L. Growth of the bacteriocin-producing Lactobacillus sakei strain CTC 494 in MRS broth is strongly reduced due to nutrient exhaustion: a nutrient depletion model for the growth of lactic acid bacteria. Appl Environ Microbiol 2001;67:4407–4413.
- Verluyten J, Leroy F & De Vuyst L: Influence of complex nutrient source on growth of and curvacin A production by sausage isolate Lactobacillus curvatus LTH 1174. Appl Environ Microbiol 2004;70:5081–5088.
- Leroy F, De Vuyst L: The presence of salt and a curing agent reduces bacteriocin production by Lactobacillus sakei CTC 494, a potential starter culture for sausage fermentation. Appl Environ Microbiol 1999;65:5350–5356.
- Verluyten J, Messens W, De Vuyst: Sodium chloride reduces production of curvacin A, a bacteriocin produced by Lactobacillus curvatus strain LTH 1174, originating from fermented sausage. Appl Environ Microbiol 2004;70:2271–2278.
- Mørtvedt CI, Nissen-Meyer J, Sletten K, Nes IF: Purification and amino acid-sequence of lactocin S, a bacteriocin produced by Lactobacillus sake L45. Appl Environ Microbiol 1991;57:1829–1834.
- Tichaczek PS, Meyer JN, Nes IF, Vogel RF, Hammes WP: Characterization of the bacteriocins curvacin A from Lactobacillus curvatus LTH1174 and sakacin P from L. sake LTH673. Syst Appl Microbiol 1992;15:460–468.
- Parente E, Ricciardi A: Production, recovery and purification of bacteriocins from lactic acid bacteria. Appl Microbiol Biotechnol 1999;52:628–638.
- Callewaert R, Holo H, Devreese B, Van Beeumen J, Nes I, De Vuyst L: Characterization and production of amylovorin L471, a bacteriocin purified from Lactobacillus amylovorus DCE 471 by a novel three-step method. Microbiology 1999;145:2559–2568.
- Callewaert R, De Vuyst L: Expanded bed adsorption as a unique unit operation for the isolation of bacteriocins from fermentation media. Bioseparation 1999;8:159–168.
- Foulquié Moreno MR, Callewaert R, De Vuyst L: Isolation of bacteriocins through expanded bed adsorption using a hydrophobic interaction medium. Bioseparation 2001;10:45–50.
- Foulquié Moreno MR, Leisner JJ, Tee LK, Ley C, Radu S, Rusul G, Vancanneyt M, De Vuyst L: Microbial analysis of Malaysian tempeh, and characterization of two bacteriocins produced by isolates of Enterococcus faecium. J Appl Microbiol 2002;92:147–157.
- Foulquié Moreno MR, Callewaert R, Devreese B, Van Beeumen J, De Vuyst L: Isolation and biochemical characterisation of enterocins produced by enterococci from different sources. J Appl Microbiol 2003;94:214–229.
- Georgalaki MD, Van den Berghe E, Kritikos D, Devreese B, Van Beeumen J, Kalantzopoulos G, De Vuyst L, Tsakalidou E: Macedocin, a food-grade lantibiotic produced by Streptococcus macedonicus ACA-DC 198. Appl Environ Microbiol 2002;68:5891–5903.
- Rodríguez JM, Martínez MI, Kok J: Pediocin PA-1, a wide-spectrum bacteriocin from lactic acid bacteria. Crit Rev Food Sci Nutr 2002;42:91–121.
- Foulquié Moreno MR, Rea MC, Cogan TM, De Vuyst L: Applicability of a bacteriocin-producing Enterococcus faecium as a co-culture in Cheddar cheese manufacture. Int J Food Microbiol 2003;81:73–84.
Leroy F, De Vuyst L: Bacteriocin-producing strains in a meat environment; in Barredo Fuente JL (eds): Methods in Biotechnology – Microbial Products and Biotransformations. Totowa, Humana Press, 2005, pp 369–380.
- Leroy F, Degeest B, De Vuyst L A novel area of predictive modelling: describing the functionality of beneficial microorganisms in foods. Int J Food Microbiol 2002;73:251–259.
- Leroy F, Lievens K, De Vuyst L: Modeling bacteriocin resistance and inactivation of Listeria innocua LMG 13568 by Lactobacillus sakei CTC 494 under sausage fermentation conditions. Appl Environ Microbiol 2005;71:7567–7570.
- Leroy F, Lievens K, De Vuyst L: Interactions of meat-associated bacteriocin-producing lactobacilli with Listeria innocua under stringent sausage fermentation conditions. J Food Prot 2005;68:2078–2084.
- Verluyten J, Messens W, De Vuyst L: The curing agent sodium nitrite, used in the production of fermented sausages, is less inhibiting to the bacteriocin-producing meat starter culture Lactobacillus curvatus LTH 1174 under anaerobic conditions. Appl Environ Microbiol 2003;69:3833–3839.
- Verluyten J, Leroy F, De Vuyst L: Effects of different spices used in production of fermented sausages on growth of and curvacin A production by Lactobacillus curvatus LTH 1174. Appl Environ Microbiol 2004;70:4807–4813.
- De Vuyst L, Avonts L, Hoste B, Vancanneyt M, Neysens P, Callewaert R: The lactobin A and amylovorin L471 genes are identical, and their distribution seems to be restricted to the species Lactobacillus amylovorus that is of interest for cereal fermentations. Int J Food Microbiol 2004;90:93–106.
- Anastasiou R, Georgalaki M, Manolopoulou E, Kandarakis I, De Vuyst L, Tsakalidou E: The performance of Streptococcus macedonicus ACA-DC 198 as starter culture in Kasseri cheese production. Int Dairy J 2006;17:208–217.
FAO/WHO: Evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO of the UN and WHO Expert Consultation Report, Cordoba 2001.
Avonts L, De Vuyst L: Antimicrobial potential of probiotic lactic acid bacteria. Proc 15th Forum for Applied Biotechnology, Gent, Sept 24–25, 2001, pp 543–550.
- Kim TS, Hur JW, Yu MA, Cheigh CI, Kim KN, Hwang JK, Pyun YR: Antagonism of Helicobacter pylori by bacteriocins of lactic acid bacteria. J Food Prot 2003;66:3–12.
- Avonts L, Van Uytven E, De Vuyst L: Cell growth and bacteriocin production of probiotic Lactobacillus strains in different media. Int Dairy J 2004;14:947–955.
- Makras L, De Vuyst L: The in vitro inhibition of Gram-negative pathogenic bacteria by bifidobacteria is caused by the production of organic acids. Int Dairy J 2006;16:1049–1057.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.